Announcement on Completion of the First Subject Enrollment in the Phase 1 Clinical Trial of KC1086

About this update from Beijing Konruns Pharmaceutical Co., Ltd. Class A

Announcement on Completion of the First Subject Enrollment in the Phase 1 Clinical Trial of KC1086The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Beijing Konruns Pharmaceutical Co., Ltd. Class A